Improvement in general touch avoidance in patients with moderate‐to‐severe genital psoriasis treated with ixekizumab during a 52‐week, randomized, phase 3 clinical trial (IXORA‐Q). - Soung, Jennifer; Cather, Jennifer C.; Gooderham, Melinda; Ryan, Caitriona; Somani, Najwa; Feely, Meghan; See, Kyoungah; Burge, Russel; Elrayes, Mohamed; Gallo, Gaia; Armstrong, April W. (JEADV Clinical Practice, 2023)